1. Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction
- Author
-
Hong-Zhuan Chen, Jinmei Jin, Xin Luan, Hong Zhang, Chao Lv, Rui Huang, Yu-Dong Zhou, Hong-Wei Zhang, Ye Wu, Weidong Zhang, Li-Jun Zhang, Sanhong Liu, and Dong Lu
- Subjects
HIF-1α, hypoxia-inducible factor-1α ,Hepatocellular carcinoma ,β-Catenin ,MST, microscale thermophoresis ,Regulator ,HIF-1α ,RM1-950 ,Carbohydrate metabolism ,03 medical and health sciences ,CETSA, cellular thermal shift assay ,0302 clinical medicine ,ROS, reactive oxygen species ,In vivo ,DARTS, drug affinity responsive target stability ,BD, bruceine D ,medicine ,ICAT, inhibitor of β-catenin and T-cell factor ,General Pharmacology, Toxicology and Pharmaceutics ,Hypoxia ,HIF-1β, hypoxia-inducible factor-1β ,030304 developmental biology ,0303 health sciences ,Gene knockdown ,ICAT ,Chemistry ,Hypoxia (medical) ,medicine.disease ,Bruceine D ,In vitro ,Metabolism ,Tumor microenvironment ,030220 oncology & carcinogenesis ,Catenin ,Cyt c, cytochrome c ,Cancer research ,Original Article ,Therapeutics. Pharmacology ,medicine.symptom ,HCC, hepatocellular carcinoma - Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths, characterized by highly hypoxic tumor microenvironment. Hypoxia-inducible factor-1α (HIF-1α) is a major regulator involved in cellular response to changes of oxygen levels, supporting the adaptation of tumor cells to hypoxia. Bruceine D (BD) is an isolated natural quassinoid with multiple anti-cancer effects. Here, we identified BD could significantly inhibit the HIF-1α expression and its subsequently mediated HCC cell metabolism. Using biophysical proteomics approaches, we identified inhibitor of β-catenin and T-cell factor (ICAT) as the functional target of BD. By targeting ICAT, BD disrupted the interaction of β-catenin and ICAT, and promoted β-catenin degradation, which in turn induced the decrease of HIF-1α expression. Furthermore, BD could inhibit HCC cells proliferation and tumor growth in vivo, and knockdown of ICAT substantially increased resistance to BD treatment in vitro. Our data highlight the potential of BD as a modulator of β-catenin/HIF-1α axis mediated HCC metabolism., Graphical abstract Bruceine D disrupted the direct interaction between ICAT and β-catenin, inducing β-catenin degradation, which in turn induced the decrease of HIF-1α expression and its subsequently mediated HCC cell metabolism.Image 1
- Published
- 2021